Piper Sandler Reiterates Overweight on Indivior, Raises Price Target to $41
Benzinga Newsdesk 12 months ago
NewsPrice TargetReiterationAnalyst Ratings
Piper Sandler analyst David Amsellem reiterates Indivior (NASDAQ:INDV) with a Overweight and raises the price target from $27 to $41.
Piper Sandler analyst David Amsellem reiterates Indivior (NASDAQ:INDV) with a Overweight and raises the price target from $27 to $41.